Silver diamine fluoride (SDF) is a solution containing ionic silver, fluoride, and ammonia that arrests the progress of carious lesions and prevents the development of future caries. The silver particle extends into the dentin tubules and could create some bonding problems for subsequent composite resin restorations placed over SDF-treated darkened tooth structures. The fluoride penetrates deeper into the tooth with SDF as compared with other fluoride solutions, creating a fluoride reservoir in the tooth structure. The fluoride component of SDF contributes to remineralization and fluorapatite formation, producing harder, more caries-resistant tooth structures. The silver provides the antimicrobial activity for the material and inhibits biofilm formation. It has been evaluated in >20 clinical studies and reviewed in systemic reviews. The material was recently approved by the Food and Drug Administration for desensitizing coldsensitive teeth and has been used off-label to treat carious lesions. SDF will produce a caries lesion darker (brown to black) than the original, which is the major criticism of the material. A nanoparticle-sized silver material was recently developed that may retain the antimicrobial properties of the larger-sized ion silver material without the discoloring effects. The application of SDF is easily adapted for field use. The lesion is isolated, and the solution is painted onto the clean caries lesion and dried. This simple application process requires little equipment, and its low cost per application makes the material ideal for large populations.
The objective of this article is to react to 2 papers presented at the ICNARA meeting (International Conference on Novel Anticaries and Remineralizing Agents), briefly review the clinical information available for silver diamine fluoride (SDF), and suggest areas for future investigations on the silvercontaining solutions. Dental caries is an infectious disease initiated by acidogenic bacteria using fermentable carbohydrates as an energy source. A succession of bacteria in the biofilm colonizes the tooth, leading to an initial subsurface lesion. Traditional treatment of the developing lesion requires removal of the caries and placement of a restoration. Restoration longevity depends on its size and seal to isolate any remaining caries. However, with early detection, the lesion can be remineralized. Fluoride (water, releasing materials, toothpastes, rinses, and varnishes) has led the preventive fight against caries. A silver-containing material, specifically SDF, has been introduced to the U.S. market as a solution that can arrest caries and prevent future carious lesion development. SDF has been used worldwide, except in the United States, for >80 y. The first use of silver involved potable water around 1000 BC (Russell and Hugo 1994) . Silver amalgam restorations produce dark interfaces between the tooth and amalgam surfaces due to corrosion of the amalgam. Stebbins hypothesized that caries inhibition could be the result of antimicrobial function of a component in the amalgam (Stebbins 1891) . Howe (1917) continued this line of reasoning and applied silver nitrate to carious lesions, which produced a black layer of sclerotic dentin that seemed to arrest future carious lesion development. Silverfluoride solutions were successfully used over the next 40 y as preventive materials in clinical as well as in vitro studies (Rosenblatt et al. 2009 ). SDF has been applied directly to carious lesions, with a significant successful clinical history of arresting and preventing dental caries (Cheng 2017 ). An excellent current review of the clinical effectiveness of SDF in children was recently published (Gao et al. 2016 ). Although SDF is not well known or used in the United States, a survey of U.S. dental schools reported that, of the 62 schools responding, 55% stated that SDF was being taught in their curricula and agreed that SDF is indicated for arresting caries on primary teeth. While application times varied, most respondents advocated applying the solution 2 times a year (Nguyen Ngoc et al. 2017) . Although SDF is available in 10%, 30%, and 38% silvercontaining solutions, the 38% solution seems to be the most effective.
The first SDF material approved by the Food and Drug Administration was Advantage Arrest (Elevate Oral Care), a 38% solution of SDF for desensitizing cold-sensitive teeth. In general, SDF solutions contain ammonia, silver, and fluoride. The fluoride content in SDF solutions varies from brand to brand. Tenuta et al. (2017) (Mei et al. 2017) , while silver is an active antimicrobial agent and ammonia stabilizes the components in the solution (Rosenblatt et al. 2009 ).
When applied to teeth, SDF penetrates enamel and dentin, and 2 to 3 times more subsurface fluoride is stored in the tooth than with other fluoride solutions (Rosenblatt et al. 2009 ). The tooth then acts as a fluoride reservoir and may increase its long-term effectiveness (Suzuki et al. 1974) . SDF reduces caries in 2 ways: Initially, it is a direct antimicrobial, as the silver reacts with thiol groups of amino and nucleic acids, disrupting metabolic and reproductive pathways of the bacteria producing cell death. Simultaneously, SDF reacts with hydroxyapatiteforming fluorapatite, reducing or preventing future caries (Rosenblatt et al. 2009 ).
Use of SDF has spread rapidly in Third World and underserved populations due to its ease of application (i.e., simply painting the solution directly on the cleaned carious lesion), its low cost per application, and its few side effects. The material can be applied in primitive settings with little dental equipment and minimal training for individuals applying it.
Advantage Arrest received approval from the Food and Drug Administration in August 2014 for treatment of dentinal hypersensitivity for adults aged >21 y. SDF has been used in other countries for more than 45 y, and multiple clinical trials have established its clinical success in arresting and preventing carious lesions. SDF may be used for controlling carious lesions as an off-label application, and patients should be advised that this is an off-label application of the material. Informed consent should be documented and placed in the treatment record. Patients should be advised that SDF will turn carious dentin and enamel dark brown or black as the soft carious dentin becomes harder and a black sclerotic surface develops.
Clinical Application of SDF
Some precautions should be followed when this material is applied to carious lesions, especially those extending below the free gingival margin, since the material may produce transient gingivitis (Nishino 1969; Mei et al. 2016) . Contact with soft tissue should be avoided by carefully applying the solution to only the lesion, using a rubber dam or cotton rolls or coating the gingival tissue with petroleum jelly to prevent gingival contact .
One or 2 drops will treat up to 5 lesions. The tooth surfaces should be kept dry during the application and isolated from tongue and cheeks with cotton rolls and gauze. The solution is applied with a microbrush and allowed to absorb for 1 min; excess is removed and rinsed with water. Although the SDF solution is clear, it will stain containers, counter tops, gloves, and skin. These brown stains on skin will eventually fade, and normal skin color will reappear, but the affected skin should be immediately washed with soap and water (Horst et al. 2016) .
The formation of metallic silver from silver compounds results in staining carious tissue black. Initially, the caries remains the same color, but after a 2-to 3-wk period, the carious tooth becomes dark brown to black. The SDF will stain noncarious dentin if the adhesive is applied over the SDF and light cured. Light exposure increases the brown-black appearance of the carious lesion. To counter this effect, researchers have investigated applying a potassium iodide (KI) solution over the SDF. The KI is applied directly over the SDF, and a white precipitate of silver iodide forms, which removes the excess silver ions. The KI is agitated until the solution turns clear and is rinsed and dried. KI is contraindicated for pregnant or breastfeeding females (Horst et al. 2016) .
Although KI is added to at least 1 commercially available SDF, 1 clinical trial reported that tooth discoloration still occurred. In a 30-mo clinical study, Li et al. (2016) assigned 83 elders to 3 treatment groups: control, SDF, or SDF followed by an application of KI. The color of the carious lesions was tracked before and after the applications by matching color squares to the carious lesions. The caries lesions were arrested in 45% of the control group, 90% of the SDF treatment group, and 93% of the SDF/KI group. KI did not decrease the dark color change.
SDF Is Very Effective
More than 20 clinical studies conducted worldwide demonstrated the success of SDF. A recent review stated that applying a 38% solution of SDF to children, adolescents (with mixed dentations), and elderly (age >60 y) produced similar results (Withers et al. 2017) . Compared with topical fluoride or fluoride varnishes, SDF produced caries arrest in 96.1% (fluoride 21.3%), and the preventive fraction (or new lesions prevented) was 70.3% with SDF and 55.7% with fluoride. Another review (Gao et al. 2016 ) stated that the active caries arrested in primary teeth treated with SDF was 81%. A clinical study reported that SDF arrests existing carious lesion (measured by explorer probing of the carious lesion) 91% at 6 mo, while fluoride arrested 70% (annual application) and glass ionomer cement, 82% (Zhi et al. 2012) . Some studies concluded that SDF was most effective with 6-mo applications (Llodra et al. 2005; Zhi et al. 2012; Withers et al. 2017) . Most clinical studies reported that caries in primary teeth is arrested slightly more than carious lesions in the permanent dentition, but more recent studies demonstrated that SDF is effective in the permanent dentition. One clinical study demonstrated that SDF promotes a faster arrest of carious lesions in permanent first molars than in primary teeth (Braga et al. 2009 ). The mean numbers of new carious surfaces in 3 randomized groups of elders-the first receiving only oral hygiene instructions (OHIs; control); the second, OHIs and SDF; and the third, OHIs/SDF and an annual oral health education lecture-were 1.3, 1.0, and 0.7, respectively, demonstrating that SDF is effective in root carious teeth in elders (Zhang et al. 2013) .
SDF Application and Adhesive Bond Strength
A review of the longevity of posterior composite resin restorations states that annual failure rates of these restorations are 1.8% and 2.4% per year at 5 and 10 y, respectively. Rates are higher for subjects at high caries risk, with failure rates at 3.2% and 4.6% per year, respectively (Belvi 2014) . A submitted paper by Seto et al. (2017) described the penetration of SDF (called silver microwires) into the dentin tubules. This occlusion of the tubules is good for reducing cold-sensitive dentin but may block the penetration of the adhesive bonding agent into the tubules and lower the bond strength of resin restorations. If the SDF-treated caries lesions are restored with composite resin and an adhesive applied to bond these restorations, the potential bond-lowering effect of the adhesive may decrease the clinical success of composite resin restorations. Selvaraj et al. (2016) and Quock et al. (2012) reported no decrease in the bond strength to SDF-treated dentin; whereas Kucukyilmaz et al. (2016) , Soeno et al. (2001) , and Knight et al. (2006) reported a decrease in shear bond strength to SDF-treated dentin. Rinsing away the precipitates resulting from SDF application prevented a decrease in bond strength for autocured glass ionomer cement (Knight et al. 2006) . Whether the bond strength-decreasing effect is permanent after an application of SDF is unknown. This area requires more investigation before composite resin is applied after a SDF application.
Effective Concentration and Application Intervals
Although several concentrations have been applied in clinical studies, 38% SDF is the most successful concentration and is effective with or without the use of tea as a reducing agent or KI. The 38% solution was significantly more effective in arresting dental caries in primary dentitions than 12% SDF and no application (control; Sharma et al. 2015) .
Fewer required applications reduce treatment costs and are favored if the effectiveness of the treatment is not compromised. One clinical study reported that an annual application of SDF solution was effective in arresting caries in primary teeth . A 3-y clinical study of 38% SDF solution demonstrated that 6-mo applications of SDF arrests caries effectively in the primary dentition (Bawden 1998) , and another clinical study evaluating application times showed that decreasing SDF application from 12 to 6 mo improved caries arrest rates (Milgrom et al. 2001) . Currently, a 6-mo application is recommended for children at high caries risk (Zhi et al. 2012) . The number of application times and the concentration of the SDF should be compared in applied clinical trials to determine the most effective frequency and concentration of SDF.
Limitations and Additional Work Needed for SDF
Safety and pulpal concerns with SDF have been examined, although SDF has an excellent safety record (Gotjamanos 1996 (Gotjamanos , 1997 . However, a recent abstract presented at the International Association for Dental Research meeting demonstrated that SDF was cytotoxic to fibroblasts in vitro 9 wk after it was applied to hydroxyapatite discs (Fancher et al. 2017 ). This small study demonstrated increased pulp cell death when the remaining dentin thickness between the applied SDF and the pulp is reduced. SDF is contraindicated for individuals with a known silver allergy, ulcerative gingivitis, or stomatitis. Although the safety of SDF is excellent, the limitations should be observed.
Two forms of silver particles are available. Ionic silver is used in commercial solutions of SDF, and nanosilver particles have only recently been developed (Schwass et al. 2017 ). This development with nanosilver particles may be as effective as SDF without producing a dark stain on the carious tooth. The nanosilver-containing material seems to be an effective antimicrobial agent due to the surface area and size of the nanosilver particles (Schwass and Meledandri 2014) . Fortunately, the nanoparticles become more antimicrobial and more transparent as the size decreases. Small spherical silver nanoparticles are almost colorless. These 10-nm particles can pass into the bacterial matrix, where they disrupt cell processes, such as DNA replication, especially for gram-negative bacteria. If this is supported by clinical and additional in vitro studies, this improvement may allow future solutions to eliminate the fluoride in the SDF solution. High levels of fluoride may produce fluorosis in children, especially when multiple applications are applied. For adults, the higher levels of fluoride are acceptable, since fluorosis does not occur after all teeth are formed.
Additional clinical work is required to determine 1) the proper concentration of silver nanoparticles that should be applied to reduce carious lesions and 2) if the silver nanoparticles also discolor the tooth. Additional studies with this material are necessary before the nanoparticle silver material can be proven successful.
Summary
SDF is an effective agent for blocking dentin tubules, reducing fluid conductance through tubules, and decreasing cold sensitivity. It is a successful antimicrobial agent: it significantly reduces the biofilm and new carious lesions while arresting existing lesions. The dark caries staining is a significant problem, and children with black anterior teeth may receive some social isolation. Restoration after SDF application may be difficult, and the short-and long-term effect on self-etching as well as total-etch adhesives should be investigated. Silver nanoparticles may provide an effective antimicrobial alternate to SDF, but significant clinical research should be conducted on this newly developed material. Although the SDF solutions are generally regarded as safe and effective, long-term clinical studies are needed to confirm the safety and clinical efficacy of the SDF and especially the developing silver nanoparticle solutions.
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